Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about EXTRACELLULAR VESICLES: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | EXTRACELLULAR VESICLES |
| Key Genes/Proteins | AGO2, ALZHEIMER, AMYLOID-BETA, amyotrophic lateral sclerosis, CAV1, CAVEOLIN-1 |
| Related Diseases | cancer, Cardiovascular, disease |
| Related Pathways | COMPLEMENT |
Knowledge base pages for this entity
graph TD
EXTRACELLULAR_VESICLES["EXTRACELLULAR VESICLES"]
EXTRACELLULAR_VESICLES -->|"modulates"| Liver["Liver"]
EXTRACELLULAR_VESICLES -->|"modulates"| Tumor_Microenvironment["Tumor Microenvironment"]
EXTRACELLULAR_VESICLES -->|"mediates"| Angiogenesis["Angiogenesis"]
EXTRACELLULAR_VESICLES -->|"mediates"| Intercellular_Communication["Intercellular Communication"]
EXTRACELLULAR_VESICLES -->|"mediates"| Metabolic_Dysfunction["Metabolic Dysfunction"]
EXTRACELLULAR_VESICLES -->|"promotes"| dopaminergic_cell_death["dopaminergic cell death"]
EXTRACELLULAR_VESICLES -.biomarker for.-> Sarcopenia["Sarcopenia"]
EXTRACELLULAR_VESICLES -->|"mediates"| Mitochondrial_Targeting["Mitochondrial Targeting"]
candesartan["candesartan"] -->|"inhibits"| EXTRACELLULAR_VESICLES
GJA1["GJA1"] -->|"regulates"| EXTRACELLULAR_VESICLES
EXOSOMES["EXOSOMES"] -->|"interacts"| EXTRACELLULAR_VESICLES
BLOOD_BRAIN_BARRIER["BLOOD-BRAIN BARRIER"] -->|"interacts"| EXTRACELLULAR_VESICLES
AKT["AKT"] -->|"regulates"| EXTRACELLULAR_VESICLES
EXTRACELLULAR_MATRIX["EXTRACELLULAR MATRIX"] -.biomarker for.-> EXTRACELLULAR_VESICLES
CANCER["CANCER"] -->|"activates"| EXTRACELLULAR_VESICLES| Target | Relation | Type | Str |
|---|---|---|---|
| Metastatic Tumor Microenvironment | associated_with | phenotype | 0.95 |
| Fatty Liver | expressed_in | disease | 0.95 |
| Mitochondria | transports | cell_type | 0.95 |
| TARDBP | transports | protein | 0.95 |
| Fatty Liver | associated_with | disease | 0.95 |
| MAPT | transports | protein | 0.95 |
| Microglia | interacts_with | cell_type | 0.92 |
| tumor microenvironment | promotes | phenotype | 0.92 |
| metastasis | promotes | process | 0.90 |
| Angiogenesis | mediates | process | 0.90 |
| Liver | modulates | cell_type | 0.90 |
| Liver | targets | cell_type | 0.90 |
| Tumor Microenvironment | modulates | phenotype | 0.90 |
| Intercellular Communication | mediates | process | 0.90 |
| miR-206-3p | associated_with | drug | 0.90 |
| Metabolic Dysfunction | mediates | phenotype | 0.88 |
| metabolic maturation | mediates | phenotype | 0.88 |
| angiogenesis | promotes | process | 0.87 |
| dopaminergic cell death | promotes | process | 0.87 |
| Tumor Metastasis | mediates | process | 0.85 |
| Functional Recovery | associated_with | phenotype | 0.85 |
| Disease Biomarker | associated_with | biomarker | 0.85 |
| Sarcopenia | biomarker_for | disease | 0.85 |
| Mitochondrial Targeting | mediates | mechanism | 0.85 |
| Mitochondrial Protection | associated_with | process | 0.85 |
| Alzheimer Disease | therapeutic_target | disease | 0.85 |
| LGALS9 | mediates | protein | 0.80 |
| immune cell infiltration | mediates | process | 0.80 |
| Organ Biodistribution | associated_with | phenotype | 0.80 |
| cryptic peptides | expressed_in | compound | 0.80 |
| Systemic metabolism | regulates | pathway | 0.80 |
| Physiological Functions | associated_with | biological_process | 0.80 |
| Immune System | participates_in | biological_process | 0.80 |
| Tissue Repair | mediates | process | 0.80 |
| Immune Modulation | mediates | process | 0.80 |
| amyloid-beta | mediates | compound | 0.80 |
| tau | mediates | protein | 0.80 |
| Antigen Presentation | participates_in | biological_process | 0.80 |
| systemic inflammation | promotes | process | 0.78 |
| IL12B | upregulates | gene | 0.75 |
| Neurodegeneration | contributes_to | disease | 0.75 |
| THBS1 | associated_with | protein | 0.70 |
| ANGPT1 | associated_with | protein | 0.70 |
| COL1A1 | associated_with | protein | 0.70 |
| Drug Delivery | associated_with | biological_process | 0.70 |
| phosphorylated tau | mediates | protein | 0.70 |
| cell-to-cell communication | regulates | process | 0.70 |
| quality control | promotes | process | 0.70 |
| Neuroinflammation | modulates | process | 0.60 |
| CHRONIC INFLAMMATION | activates | concept | 0.50 |
| Source | Relation | Type | Str |
|---|---|---|---|
| P2RX7 | regulates | gene | 0.95 |
| fatty liver | promotes | phenotype | 0.95 |
| MIR130A | expressed_in | gene | 0.92 |
| TGFB1 | expressed_in | protein | 0.90 |
| Brown Adipose Tissue | associated_with | cell_type | 0.90 |
| ITGAV | targets | gene | 0.90 |
| ITGB8 | targets | gene | 0.90 |
| candesartan | inhibits | drug | 0.88 |
| Cancer | associated_with | disease | 0.85 |
| cryptic peptides | expressed_in | compound | 0.85 |
| hepatic steatosis | associated_with | disease | 0.85 |
| Sarcopenia | associated_with | disease | 0.85 |
| GJA1 | involved_in | gene | 0.80 |
| ASTROCYTE | expresses | gene | 0.70 |
| motor skill learning | modulates | process | 0.70 |
| LRRK2 | promotes | protein | 0.70 |
| GJA1 | regulates | gene | 0.70 |
| Sod1 | associated_with | gene | 0.50 |
| Stem Cell | associated_with | cell_type | 0.50 |
| Autophagy | activates | process | 0.50 |
| PARKINSON | activates | gene | 0.50 |
| Parkinson's Disease | activates | disease | 0.50 |
| disease | activates | disease | 0.50 |
| PARKINSON'S | activates | concept | 0.50 |
| DOPAMINE | activates | concept | 0.50 |
| PARKINSON | interacts_with | gene | 0.50 |
| PARKINSON'S | interacts_with | concept | 0.50 |
| ENDOTHELIAL | associated_with | concept | 0.50 |
| MITOCHONDRIA | activates | cell_type | 0.50 |
| Tdp-43 | associated_with | pathway | 0.50 |
| IMMUNE RESPONSE | activates | pathway | 0.50 |
| NEURONS | activates | concept | 0.50 |
| GENE EXPRESSION | activates | concept | 0.50 |
| STEM CELLS | activates | concept | 0.50 |
| Proteins | interacts_with | protein | 0.50 |
| AMYLOID-BETA | activates | protein | 0.50 |
| ALZHEIMER | activates | gene | 0.50 |
| Neuron | activates | cell_type | 0.50 |
| EXOSOMES | activates | concept | 0.50 |
| Proteins | expressed_in | protein | 0.50 |
| disease | associated_with | disease | 0.50 |
| Proteins | regulates | protein | 0.50 |
| Cardiovascular | associated_with | disease | 0.50 |
| Sod1 | activates | gene | 0.50 |
| amyotrophic lateral sclerosis | activates | gene | 0.50 |
| COMPLEMENT | activates | pathway | 0.50 |
| MITOCHONDRIA | regulates | cell_type | 0.50 |
| P2RX7 | regulates | gene | 0.50 |
| Tauopathy | regulates | disease | 0.50 |
| microglia | activates | cell_type | 0.50 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Hypothesis 3: HepaCAM-Containing Extracellular Vesicles | 0.762 | neurodegeneration | View |
| Blocking Tau Packaging into Small Extracellular Vesicles via | 0.610 | neuroscience | Trans-synaptic tau spreading and propaga |
| Ganglioside-rich extracellular vesicles preserve alpha-synuc | 0.582 | neurodegeneration | Which specific CSF molecular components |
| Tumor-derived extracellular vesicles as TREM2 ligands | 0.490 | neurodegeneration | Does the cancer-cystatin-C-TREM2 pathway |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning EXTRACELLULAR VESICLES in their description or question text
No additional research found